We are live on ! Find out more
FCM

Findell Capital Management Portfolio holdings

AUM $710M
1-Year Est. Return 250.3%
This Fund
S&P 500
This Quarter Est. Return
-2.23%
1 Year Est. Return
+250.3%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$341M
AUM Growth
-$6.32M
Cap. Flow
+$21.9M
Cap. Flow %
6.42%
Top 10 Hldgs %
90.53%
Holding
22
New
5
Increased
8
Reduced
5
Closed
4

Top Buys

Rank Stock Value
1
LQDA icon
Liquidia Corp
LQDA
+$24.1M
2
DAVE icon
Dave Inc
DAVE
+$19.4M
3
ROOT icon
Root
ROOT
+$8.17M
4
CVE icon
Cenovus Energy
CVE
+$8M
5
ACHC icon
Acadia Healthcare
ACHC
+$6.88M

Top Sells

Rank Stock Value
1
ESTA icon
Establishment Labs
ESTA
+$9.06M
2
LRN icon
Stride
LRN
+$5.84M
3
ADMA icon
ADMA Biologics
ADMA
+$5.47M
4
TPB icon
Turning Point Brands
TPB
+$3.57M
5
VOR icon
Vor Biopharma
VOR
+$3.02M

Sector Composition

Rank Sector Weight
1 Healthcare 62.93%
2 Technology 9.85%
3 Financials 8.63%
4 Consumer Discretionary 4.74%
5 Consumer Staples 4.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LQDA icon
1
Liquidia Corp
LQDA
$6.66B
$132M 38.71%
3,502,112
+650,663
+23% +$24.1M
ESTA icon
2
Establishment Labs
ESTA
$2.37B
$56.7M 16.59%
997,747
-132,713
-12% -$9.06M
DAVE icon
3
Dave Inc
DAVE
$4.27B
$29.6M 8.67%
170,000
+100,000
+143% +$19.4M
ROOT icon
4
Root
ROOT
$797M
$16.6M 4.85%
375,000
+140,000
+60% +$8.17M
SGHC icon
5
SGHC Ltd
SGHC
$6.76B
$16.2M 4.74%
1,500,000
+560,000
+60% +$5.71M
GEO icon
6
The GEO Group
GEO
$4.11B
$14.7M 4.31%
875,000
+225,000
+35% +$3.57M
OPRT icon
7
Oportun Financial
OPRT
$355M
$12.7M 3.71%
2,748,300
+180,000
+7% +$916K
ABVX
8
Abivax
ABVX
$10.4B
$11.7M 3.42%
105,000
+57,000
+119% +$6.75M
CVE icon
9
Cenovus Energy
CVE
$57.2B
$9.95M 2.91%
+375,000
New +$8M
ACHC icon
10
Acadia Healthcare
ACHC
$2.87B
$8.89M 2.6%
+380,000
New +$6.88M
TPB icon
11
Turning Point Brands
TPB
$1.75B
$8.25M 2.41%
95,000
-32,000
-25% -$3.57M
CELH icon
12
Celsius Holdings
CELH
$7.36B
$7.1M 2.08%
200,000
-10,000
-5% -$474K
MLYS icon
13
Mineralys Therapeutics
MLYS
$2.27B
$5.47M 1.6%
202,000
+152,000
+304% +$4.46M
VET icon
14
Vermilion Energy
VET
$1.73B
$5.1M 1.49%
+370,000
New +$3.92M
APLD icon
15
Applied Digital
APLD
$8.98B
$4.04M 1.18%
+170,000
New +$5.32M
LQDA icon
16
CALL
Liquidia Corp
LQDA
$6.66B
$1.89M 0.55%
50,000
-106,000
-68% -$3.93M
BTU icon
17
Peabody Energy
BTU
$3.11B
$276K 0.08%
+8,381
New +$293K
EHTH icon
18
eHealth
EHTH
$39.1M
$231K 0.07%
179,027
-1,229,948
-87% -$2.85M
ADMA icon
19
ADMA Biologics
ADMA
$2.12B
-300,000
Closed -$5.47M
LQDA icon
20
PUT
Liquidia Corp
LQDA
$6.66B
-1,200,000
Closed -$41.4M
LRN icon
21
Stride
LRN
$3.46B
-90,000
Closed -$5.84M
VOR icon
22
Vor Biopharma
VOR
$1.36B
-231,000
Closed -$3.02M

Similar funds

Findell Capital Management's Q1 2026 Portfolio in Review

As of Q1 2026, Findell Capital Management held 22 positions worth $341M, down 1.8% from $348M the previous quarter. Its ten largest holdings account for 91% of the portfolio.

Findell Capital Management deployed $21.9M of net new capital in Q1 2026, opening 5 new positions and adding to 8 existing holdings. Its largest new stake was Cenovus Energy: 375,000 shares worth $9.95M.

By sector, the portfolio is most concentrated in Healthcare at 63% of assets, up from 57% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Establishment Labs, an estimated $9.06M trimmed.

  • Findell Capital Management's largest Q1 2026 buy was Cenovus Energy: 375,000 shares worth $9.95M.
  • Findell Capital Management added most to Liquidia Corp in Q1 2026, an estimated $24.1M increase.
  • Findell Capital Management's biggest Q1 2026 reduction was Establishment Labs, cutting an estimated $9.06M.
  • Findell Capital Management fully exited Stride in Q1 2026, selling an estimated $5.84M.
  • Findell Capital Management's ten largest holdings make up 91% of its $341M portfolio in Q1 2026.
  • Findell Capital Management opened 5 new positions and closed 4 in Q1 2026.
  • Findell Capital Management's portfolio value fell 1.8% quarter-over-quarter to $341M.

Based on Findell Capital Management's 13F filing for Q1 2026, filed 15 May 2026.